Clinical Trials Browser

Meningioma × abemaciclib × Clear all

NCT02523014 2026-04-07

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Phase 2 Recruiting

Meningioma

NCT05940493 2026-03-13

Abemaciclib in Newly Diagnosed Meningioma Patients

Phase 2 Recruiting

Meningioma

NCT03220646 2025-07-09

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Phase 2 Active not recruiting

Astrocytoma, Brain Neoplasms, Ependymoma, Meningioma, Oligodendroglioma